59.92
Nektar Therapeutics Aktie (NKTR) Neueste Nachrichten
Is Nektar Therapeutics trending in predictive chart modelsJuly 2025 Closing Moves & Long-Term Capital Growth Strategies - newser.com
Why Nektar Therapeutics stock remains on buy listsWeekly Risk Summary & Fast Exit/Entry Strategy Plans - newser.com
Published on: 2025-11-03 04:48:43 - newser.com
Why Nektar Therapeutics stock remains undervaluedJuly 2025 Outlook & Safe Capital Preservation Plans - newser.com
Will Nektar Therapeutics stock benefit from AI adoptionPortfolio Gains Summary & Community Consensus Picks - newser.com
Can Nektar Therapeutics (ITH0) stock sustain free cash flow2025 Price Momentum & AI Forecasted Entry and Exit Points - newser.com
What margin trends mean for Nektar Therapeutics stockJuly 2025 Trade Ideas & Capital Efficient Trading Techniques - newser.com
Why retail investors pile into Nektar Therapeutics stockInsider Selling & Real-Time Price Movement Reports - newser.com
Is Nektar Therapeutics stock a good choice for value investorsGap Up & Weekly Market Pulse Updates - newser.com
Using economic indicators to assess Nektar Therapeutics potential2025 Year in Review & Daily Momentum Trading Reports - newser.com
Moody Aldrich Partners LLC Invests $1.17 Million in Nektar Therapeutics $NKTR - MarketBeat
Will Nektar Therapeutics continue its uptrend2025 Analyst Calls & AI Driven Price Predictions - newser.com
Nektar Therapeutics (NKTR): Valuation Reset as REZOLVE-AD Phase 2b Data and Analyst Optimism Drive Investor Interest - simplywall.st
Is Nektar Therapeutics (ITH0) stock undervalued at current priceQuarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com
Nektar Therapeutics (NASDAQ:NKTR) Reaches New 1-Year HighShould You Buy? - MarketBeat
Is Nektar Therapeutics (ITH0) stock a top dividend aristocrat candidateJuly 2025 Gainers & Comprehensive Market Scan Reports - newser.com
Nektar Therapeutics stock hits 52-week high at 65.97 USD By Investing.com - Investing.com Australia
Nektar Therapeutics (NKTR) Is Up 8.0% After Late-Breaking Phase 2b Rezpegaldesleukin Data Announcement - Sahm
Nektar Therapeutics stock hits 52-week high at 65.97 USD - Investing.com
Best data tools to analyze Nektar Therapeutics stock2025 Market Trends & Detailed Earnings Play Strategies - newser.com
Nektar Therapeutics (NKTR): Taking a Fresh Look at Valuation After Recent Share Price Rebound - Yahoo Finance
Can volume confirm reversal in Nektar TherapeuticsJuly 2025 Update & Free Real-Time Market Sentiment Alerts - newser.com
Pattern recognition hints at Nektar Therapeutics upsideRecession Risk & Real-Time Market Trend Scan - newser.com
Nektar (NASDAQ: NKTR) to Webcast Jefferies London Event Nov. 20 with 30-day Replay - Stock Titan
Nektar Therapeutics (NKTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Nektar Therapeutics $NKTR Holdings Trimmed by Deuterium Capital Management LLC - MarketBeat
Can Nektar Therapeutics stock resist market sell offsJuly 2025 Movers & Weekly High Return Opportunities - newser.com
Nektar Therapeutics (NKTR) to Release Earnings on Thursday - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):